Capable
5 known investors
Capable is a vertically integrated, AI-enabled deeptech platform developing peptide and nucleotide therapeutics using automated polymer synthesis, drawing on rare human genetic variants. Its first programs focus on sleep, targeting rare sleep diseases such as narcolepsy and hypersomnia with therapeutics aimed at improving cognitive performance under sleep deprivation.
AI & Machine LearningBiotechDeep Tech
Investors · 5
In the news
Frequently asked questions
- What does Capable do?
- Capable is a vertically integrated, AI-enabled deeptech platform developing peptide and nucleotide therapeutics using automated polymer synthesis, drawing on rare human genetic variants. Its first programs focus on sleep, targeting rare sleep diseases such as narcolepsy and hypersomnia with therapeutics aimed at improving cognitive performance under sleep deprivation.
- Who are Capable's investors?
- Capable's investors include GoAhead Ventures, HOF Capital, Able Partners, AlleyCorp, M13.